Showing results (581-590 of 868) with videos related to

Sort By:
Pageof 87
Thrombosis and Haemostasis|September 2, 2016
Clinical presentation and course of bleeding events in patients with venous thromboembolism, treated with apixaban or enoxaparin and warfarin. Results from the AMPLIFY trialSuzanne M Bleker, Alexander T Cohen, Harry R Büller, et al.
The New England Journal of Medicine|July 2, 2013
Oral apixaban for the treatment of acute venous thromboembolismGiancarlo Agnelli, Harry R Buller, Alexander Cohen, et al.
Research and Practice in Thrombosis and Haemostasis|March 18, 2021
Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high- and low-dose rivaroxaban with aspirinKochawan Boonyawat, Anthonie W A Lensing, Martin H Prins, et al.
The New England Journal of Medicine|March 19, 2019
Antibody-Based Ticagrelor Reversal Agent in Healthy VolunteersDeepak L Bhatt, Charles V Pollack, Jeffrey I Weitz, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 30, 2012
Subtle differences in commercial heparins can have serious consequences for cardiopulmonary bypass patients: A randomized controlled trialKyle A Arsenault, Jeremy S Paikin, Jack Hirsh, et al.
Bioactive Materials|April 22, 2026
AI-assisted phage formulation delivered via injectable hydrogels for localized control of implant-associated infectionsFereshteh Bayat, Martin Stark, Sara Rahmani, et al.
Annals of Surgery|December 5, 2012
Postoperative outcomes after laparoscopic splenectomy compared with open splenectomyKhaled M Musallam, Mohamed Khalife, Pierre M Sfeir, et al.
Research and Practice in Thrombosis and Haemostasis|February 17, 2023
Factor V Leiden but not the factor II 20210G>A mutation is a risk factor for premature coronary artery disease: a case-control study in IranPasquale Agosti, Ilaria Mancini, Saeed Sadeghian, et al.
European Journal of Haematology|February 24, 2023
Prophylaxis with recombinant von Willebrand factor in patients with type 3 von Willebrand disease: Results of a post hoc analysis from a phase 3 trialFrank W G Leebeek, Flora Peyvandi, Andreas Tiede, et al.
Journal of Thrombosis and Thrombolysis|December 18, 2012
Dabigatran attenuates thrombin generation to a lesser extent than warfarin: could this explain their differential effects on intracranial hemorrhage and myocardial infarction?Brian Dale, John W Eikelboom, Jeffrey I Weitz, et al.
Pageof 87